Sharper Sense, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sharper Sense, Inc. - overview
Established
2020
Location
New York, NY, US
Primary Industry
Biotechnology
About
Founded in 2020 and based in New York, Sharper Sense, Inc. develops innovative neuromodulation solutions to enhance sensory perception through noninvasive wearable technology. Sharper Sense, Inc. specializes in creating neuromodulation patches that improve sensory acuity.
Founded in 2020 in New York, the company was co-founded by Charles Rodenkirch and Qi Wang. In August 2021, the firm raised USD 425,000 in Seed funding, with investments from Cornell University and Joyance Partners. The total amount raised by the company stands at USD 425,000, with only one recorded deal to date. Sharper Sense is primarily engaged in the development and commercialization of a neuromodulation patch designed to enhance sensory perception.
This innovative product is worn on the neck and functions by stimulating a nerve that connects to the brain, thereby optimizing mental states and improving the accuracy of hearing, vision, and touch. The patch is developed to be noninvasive, safe, and comfortable, appealing to diverse users such as athletes, gamers, operators, artists, students, and older adults. By enhancing sensory acuity, Sharper Sense aims to address various use cases where heightened sensory perception is critical, including performance and safety in high-stakes environments. The product is marketed in North America, Europe, and parts of Asia, targeting individual consumers and professional sectors that benefit from enhanced sensory capabilities.
The revenue structure of Sharper Sense is fundamentally based on direct-to-consumer sales and potential partnerships with organizations requiring heightened sensory performance. The company offers its neuromodulation patch through various sales channels, including online platforms and direct retail partnerships, allowing them to reach a broad customer base. Pricing models are structured around individual sales of the patch, with potential subscription options for ongoing enhancements or related services, although specific pricing details are not disclosed. This approach positions Sharper Sense to cater to both individual users seeking improved sensory experiences and professional entities that may utilize the product in operational settings.
The company's flagship product, the neuromodulation patch, signifies its innovative edge within the sensory enhancement market. In August 2021, Sharper Sense, Inc. raised USD 425,000 in Seed funding to further its growth strategy. The company plans to develop additional neuromodulation products aimed at enhancing sensory experiences, with a targeted release in the upcoming year.
Additionally, Sharper Sense is exploring expansion into new markets in Asia and Europe to increase its global footprint by the end of 2023. The recent funding will support these initiatives, enabling the development of new products and facilitating entry into additional geographic regions.
Current Investors
Joyance Partners, Cornell University
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.sharpersense.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.